Mean number of pharmacist visits per 100 patient-years with respiratory and other medications dispensed
Years before index | Patients with COPD | Comparator subjects | ||||||||
5 | 4 | 3 | 2 | 1 | 5 | 4 | 3 | 2 | 1 | |
ICS | 26 | 28 | 29 | 33 | 43 | 6 | 6 | 6 | 6 | 6 |
LABA | 3 | 3 | 4 | 4 | 5 | 1 | 1 | 1 | 1 | 1 |
ICS/LABA | 10 | 12 | 15 | 20 | 31 | 2 | 2 | 2 | 3 | 4 |
LAMA | 1 | 1 | 2 | 3 | 5 | 0 | 0 | 0 | 0 | 0 |
LABA | 3 | 3 | 4 | 4 | 5 | 1 | 1 | 1 | 1 | 1 |
LAMA/LABA | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SABA | 44 | 48 | 52 | 61 | 85 | 8 | 8 | 8 | 9 | 9 |
SAMA | 8 | 10 | 12 | 16 | 27 | 1 | 1 | 1 | 2 | 2 |
SAMA/SABA | 2 | 3 | 4 | 4 | 6 | 0 | 0 | 0 | 0 | 0 |
Other respiratory medications | 21 | 24 | 26 | 30 | 42 | 10 | 11 | 11 | 13 | 14 |
Non-respiratory medications | 1141 | 1226 | 1320 | 1441 | 1612 | 766 | 817 | 871 | 937 | 1007 |
COPD, chronic obstructive pulmonary disease; ICS, inhaled corticosteroids; LABA, long-acting beta-agonists; LAMA, long-acting muscarinic agents; SABA, short-acting beta-agonists; SAMA, short-acting muscarinic agents.